121 related articles for article (PubMed ID: 32008993)
1. Optimal acquisition time to discriminate between breast cancer subtypes with contrast-enhanced cone-beam CT.
Chen JT; Zhou CY; He N; Wu YP
Diagn Interv Imaging; 2020 Jun; 101(6):391-399. PubMed ID: 32008993
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced cone-beam breast-CT: Analysis of optimal acquisition time for discrimination of breast lesion malignancy.
Uhlig J; Fischer U; Surov A; Lotz J; Wienbeck S
Eur J Radiol; 2018 Feb; 99():9-16. PubMed ID: 29362157
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI.
Wienbeck S; Fischer U; Luftner-Nagel S; Lotz J; Uhlig J
Eur Radiol; 2018 Sep; 28(9):3731-3741. PubMed ID: 29594402
[TBL] [Abstract][Full Text] [Related]
4. CT values of contrast-enhanced CBBCT: A useful diagnostic tool for benign and malignant breast lesions.
Wei W; Yi XL; Yang J; Liao H; Su D
Acta Radiol; 2023 Aug; 64(8):2379-2386. PubMed ID: 37287251
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced cone beam breast CT features of breast cancers: correlation with immunohistochemical receptors and molecular subtypes.
Ma Y; Liu A; O'Connell AM; Zhu Y; Li H; Han P; Yin L; Lu H; Ye Z
Eur Radiol; 2021 Apr; 31(4):2580-2589. PubMed ID: 33009590
[TBL] [Abstract][Full Text] [Related]
6. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of cone-beam breast computed tomography: a systematic review and diagnostic meta-analysis.
Uhlig J; Uhlig A; Biggemann L; Fischer U; Lotz J; Wienbeck S
Eur Radiol; 2019 Mar; 29(3):1194-1202. PubMed ID: 30255249
[TBL] [Abstract][Full Text] [Related]
8. Novel Breast Imaging and Machine Learning: Predicting Breast Lesion Malignancy at Cone-Beam CT Using Machine Learning Techniques.
Uhlig J; Uhlig A; Kunze M; Beissbarth T; Fischer U; Lotz J; Wienbeck S
AJR Am J Roentgenol; 2018 Aug; 211(2):W123-W131. PubMed ID: 29792725
[TBL] [Abstract][Full Text] [Related]
9. The cone-beam breast computed tomography characteristics of breast non-mass enhancement lesions.
Kang W; Zhong W; Su D
Acta Radiol; 2021 Oct; 62(10):1298-1308. PubMed ID: 33070636
[TBL] [Abstract][Full Text] [Related]
10. Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE.
Lucatelli P; De Rubeis G; Basilico F; Ginanni Corradini L; Corona M; Bezzi M; Catalano C
Radiol Med; 2019 Dec; 124(12):1212-1219. PubMed ID: 31473930
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Enhanced Cone-Beam Breast CT: An Analysis of Diagnostic Value in Predicting Breast Lesion With Rim Enhancement Malignancy.
Zhao X; Yang J; Zuo Y; Kang W; Liao H; Zheng ZT; Su DK
Front Oncol; 2022; 12():868975. PubMed ID: 35686106
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesions.
Janu E; Krikavova L; Little J; Dvorak K; Brancikova D; Jandakova E; Pavlik T; Kovalcikova P; Kazda T; Valek V
BMC Med Imaging; 2020 Jun; 20(1):66. PubMed ID: 32552678
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced dedicated breast CT: initial clinical experience.
Prionas ND; Lindfors KK; Ray S; Huang SY; Beckett LA; Monsky WL; Boone JM
Radiology; 2010 Sep; 256(3):714-23. PubMed ID: 20720067
[TBL] [Abstract][Full Text] [Related]
14. Pre- and post-contrast versus post-contrast cone-beam breast CT: can we reduce radiation exposure while maintaining diagnostic accuracy?
Uhlig J; Fischer U; Biggemann L; Lotz J; Wienbeck S
Eur Radiol; 2019 Jun; 29(6):3141-3148. PubMed ID: 30488110
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of sporadic intracranial cavernous malformations for detecting associated developmental venous anomalies: added diagnostic value of C-arm contrast-enhanced cone-beam CT to routine contrast-enhanced MRI.
Kocak B; Kizilkilic O; Zeynalova A; Korkmazer B; Kocer N; Islak C
Eur Radiol; 2019 Feb; 29(2):783-791. PubMed ID: 30066249
[TBL] [Abstract][Full Text] [Related]
16. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
17. WE-G-217BCD-08: Image Quality Effects of Dynamic Iodine Concentrations for Contrast-Enhanced Cone-Beam CT.
Jones B; Altunbas C; Kavanagh B; Miften M
Med Phys; 2012 Jun; 39(6Part28):3974. PubMed ID: 28519608
[TBL] [Abstract][Full Text] [Related]
18. The utility of breast cone-beam computed tomography, ultrasound, and digital mammography for detecting malignant breast tumors: A prospective study with 212 patients.
He N; Wu YP; Kong Y; Lv N; Huang ZM; Li S; Wang Y; Geng ZJ; Wu PH; Wei WD
Eur J Radiol; 2016 Feb; 85(2):392-403. PubMed ID: 26781145
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of (99m)Tc-3PRGD2 scintimammography for differentiation of malignant from benign breast lesions: Comparison of visual and semi-quantitative analysis.
Chen Q; Xie Q; Zhao M; Chen B; Gao S; Zhang H; Xing H; Ma Q
Hell J Nucl Med; 2015; 18(3):193-8. PubMed ID: 26574690
[TBL] [Abstract][Full Text] [Related]
20. Contrast Enhancement on Cone-Beam Breast-CT for Discrimination of Breast Cancer Immunohistochemical Subtypes.
Uhlig J; Fischer U; von Fintel E; Stahnke V; Perske C; Lotz J; Wienbeck S
Transl Oncol; 2017 Dec; 10(6):904-910. PubMed ID: 28946110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
